Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 

New acceleration techniques will :
reduce scan times 
cause artifacts 
increase expenses 
be useful if you have a lot of experience 
doesn't do much 
never heard of 




 
MRI News Service:
'Gadobutrol'  p2
SEARCH NEWS FOR   
 
Result: Searchterm 'Gadobutrol' found in 12 news
Result Pages
More Results: Database  (2)  
News     News Refinements:  Contrast Agents  Devices  Financial  
FDA Accepts New Drug Application for Gadovist® 1.0 Injection in Magnetic Resonance Imaging
''Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance ...'
Wednesday, 4 August 2010   by viva.vita.bayerhealthcare.de
Gadograf, Gadovist
''Gadovist/Gadograf 1.0 mmol/ml contains gadobutrol, a neutral macrocyclic gadolinium (Gd) complex with contrast-enhancing properties, which is used for magnetic resonance imaging (MRI). MRI is a widely used technique for the evaluation and detection of ...'
Friday, 13 April 2007   by www.ema.europa.eu
News     News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
If an elderly but distinguished scientist says that something is possible he is almost certainly right, but if he says that it is impossible he is very probably wrong.
- Arthur C. Clarke
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 15 May 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]